Diabetes Drug could Reduce Alzheimer’s Risk, Study Reports

July 14, 2014 3:22 PM

8 0

According to a large German study, an affordable generic diabetes drug might be able to cut one's risk of developing Alzheimer's disease, the most common form of dementia. The researchers of the clinical trial reported that the type 2 diabetes drug, pioglitazone, which is sold as Actos created by Takeda Pharmaceutical Co Ltd, prevented the onset of Alzheimer's.

In this analysis, the researchers from the German Center for Neurodegenerative Diseases looked at data taken from German healthcare plans between 2004 and 2010. There were 145,717 patients who were 60-years-old or older. None of them had any signs of dementia at the beginning of the study. The resea...

Also read: House Passes Health Bill to Speed Drug Approvals, Boost Biomedical Research

Read more

To category page

Loading...